12th May 2026 07:00
12 May 2026
Craneware plc
("Craneware", or the "Company")
Transaction in Own Shares
Craneware (AIM: CRW.L), a leader in healthcare financial performance solutions, announces it has purchased the following number of its Ordinary Shares of 1p each through Joh. Berenberg, Gossler & Co. KG, London Branch ("Berenberg") on the London Stock Exchange.
Date of purchases: | 05 to 11 May 2026 |
Aggregate number of Ordinary Shares purchased: | 193,334 |
Lowest price paid per share (GBp): | 1,532.94 |
Highest price paid per share (GBp): | 1,606.00 |
Volume weighted average price paid per share (GBp): | 1,563.05 |
The Company will hold the purchased shares in Treasury. Following the purchase of these shares, the Company will have 34,280,282 Ordinary Shares in issue (excluding Treasury shares), and the Company will hold 1,261,887 Ordinary Shares in Treasury.
The figure of 34,280,282 represents the total voting rights in the Company and may be used by shareholders as the denominator for calculating whether they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.
The table below contains detailed information about the purchases made as part of the buyback programme which was announced by the Company on 16 March 2026 (the "Programme").
Schedule of Purchases - Individual Transactions
In accordance with Article 5(1)(b) of the Market Abuse Regulation (EU) No 596/2014 as it forms part of UK law, a full breakdown of the individual trades made by Berenberg on behalf of the Company as part of the Programme is detailed below:
Number of ordinary shares purchased | Transaction price (GBp share) | Time of transaction (UK Time) | Transaction reference number | Trading Venue |
| |
2,500 | 1538.00 | 05.05.2026 08:41:32 | 00066949098TRLO1 | LSE | ||
3,000 | 1534.38 | 05.05.2026 10:34:38 | 00066958639TRLO1 | LSE | ||
5,000 | 1550.00 | 05.05.2026 10:52:48 | 00066961789TRLO1 | LSE | ||
2,500 | 1578.00 | 05.05.2026 12:21:34 | 00066969108TRLO1 | LSE | ||
12,500 | 1574.59 | 05.05.2026 14:09:02 | 00066978152TRLO1 | LSE | ||
9,500 | 1575.00 | 05.05.2026 14:09:15 | 00066978170TRLO1 | LSE | ||
10,800 | 1575.00 | 05.05.2026 14:10:25 | 00066978265TRLO1 | LSE | ||
2,500 | 1606.00 | 06.05.2026 13:05:00 | 00067035183TRLO1 | LSE | ||
2,500 | 1551.00 | 06.05.2026 08:30:00 | 00067012757TRLO1 | LSE | ||
7,500 | 1600.00 | 06.05.2026 09:51:00 | 00067019100TRLO1 | LSE | ||
34,307 | 1605.28 | 06.05.2026 13:54:00 | 00067037641TRLO1 | LSE | ||
5,500 | 1555.16 | 07.05.2026 14:01:00 | 00067149776TRLO1 | LSE | ||
4,000 | 1558.99 | 08.05.2026 09:39:56 | 00067309800TRLO1 | LSE | ||
5,000 | 1551.18 | 08.05.2026 13:28:36 | 00067318129TRLO1 | LSE | ||
38,317 | 1548.19 | 08.05.2026 15:49:25 | 00067330339TRLO1 | LSE | ||
1,000 | 1537.96 | 11.05.2026 09:48:00 | 00067346722TRLO1 | LSE | ||
1,500 | 1546.00 | 11.05.2026 10:14:00 | 00067347379TRLO1 | LSE | ||
2,000 | 1545.23 | 11.05.2026 11:22:00 | 00067349157TRLO1 | LSE | ||
7,500 | 1539.33 | 11.05.2026 12:33:00 | 00067351265TRLO1 | LSE | ||
4,250 | 1535.00 | 11.05.2026 13:57:00 | 00067354195TRLO1 | LSE | ||
12,000 | 1533.94 | 11.05.2026 15:19:00 | 00067362127TRLO1 | LSE | ||
19,660 | 1532.94 | 11.05.2026 15:30:00 | 00067363698TRLO1 | LSE |
For further information please contact:
Craneware plc +44 (0)131 550 3100
Keith Neilson, CEO
Craig Preston, CFO
Alma Strategic Communications +44 (0)20 3405 0205
Caroline Forde, Kinvara Verdon, Louisa El-Ahwal [email protected]
About Craneware
For over 25 years, The Craneware Group (AIM:CRW.L) has been a leader in healthcare financial and operational transformation, delivering cutting-edge technologies that drive measurable impact. Our Trisus® cloud ecosystem unifies data, revenue intelligence, margin intelligence, and advanced analytics, enabling healthcare organizations to optimize performance, improve financial sustainability, and drive strategic growth. As a trusted Microsoft partner, we provide future-ready solutions-including the Best in KLAS Trisus Chargemaster - that simplify the complexities of healthcare finance and operations. What sets us apart is our unique combination of deep healthcare expertise and engineering excellence, positioning us as a strategic partner rather than just a technology provider. The Craneware Group empowers healthcare organizations to achieve sustainable financial success while delivering better outcomes for the communities they serve - today and in the future. Together, we are transforming the business of healthcare.
Learn more at www.thecranewaregroup.com
Related Shares:
Craneware